PTX 0.00% 4.1¢ prescient therapeutics limited

Median PFS of 12.2 months for all assessable r/r TCL patients;...

  1. 27 Posts.
    lightbulb Created with Sketch. 28
    Median PFS of 12.2 months for all assessable r/r TCL patients; 13.6 month for r/r CTCL and 7.4 months for r/r PTCL. For context, several key opinion leaders consider a benchmark median PFS for a registration study in r/r TCL is 5-6 months.

    Great announcement regardless of where the share price lands today, setting up for a optimistic and eventful 2024.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.000(0.00%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $19.26K 479.3K

Buyers (Bids)

No. Vol. Price($)
1 258511 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 238998 5
View Market Depth
Last trade - 13.09pm 18/09/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.